BioHarvest revenue rises 3.8% to $8.8 million
BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8%, while gross margin slipped to 58%.
BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8%, while gross margin slipped to 58%.
Aramark (NYSE:ARMK) reported fiscal third-quarter 2026 revenue growth of 9%, while adjusted EPS increased 29% to $0.52.
Sea (NYSE:SE) reported second-quarter 2026 GAAP revenue of US$7.8 billion, up 48.1%, while net income increased 10.6% to US$458.1 million.
Shattuck Labs (NASDAQ:STTK) reported a $15.2 million Q2 2026 net loss with no revenue while advancing lead candidate SL-325.
Ampco-Pittsburgh (NYSE:AP) reported second-quarter 2026 net sales of $102.9 million, down 9% year over year, while attributable net income reached $1.5 million.
Flowco Holdings (NYSE:FLOC) reported second-quarter 2026 revenue of $235.9 million, net income of $30.9 million and adjusted EBITDA of $93.9 million.
Organigram Global (NASDAQ:OGI) reported $145.1 million in third-quarter gross revenue alongside a net income of $105.5 million.
RBA Governor Michele Bullock stated that inflation risks remain skewed to the upside due to a strong labour market.
Trump Media & Technology Group (NASDAQ:DJT) reported a second-quarter 2026 net loss of $238.1 million on revenue of $1.7 million.
On Holding (NYSE:ONON) reported second-quarter 2026 net sales of CHF850.3 million, up 13.5% year over year and 21.6% at constant currencies.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas